- Home
- CB vs MDT Comparison
CB vs MDT Comparison
Compare CB & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CB | MDT |
|---|---|---|
| Founded | 1985 | 1949 |
| Country | Switzerland | Ireland |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.7B | 131.9B |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CB | MDT |
|---|---|---|
| Price | $323.52 | $87.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 19 |
| Target Price | ★ $331.90 | $109.82 |
| AVG Volume (30 Days) | 1.5M | ★ 7.1M |
| Earning Date | 04-21-2026 | 02-17-2026 |
| Dividend Yield | 1.20% | ★ 3.24% |
| EPS Growth | 13.13 | ★ 30.80 |
| EPS | ★ 25.68 | 2.76 |
| Revenue | ★ $59,402,000,000.00 | $33,537,000,000.00 |
| Revenue This Year | N/A | $8.91 |
| Revenue Next Year | $5.31 | $6.71 |
| P/E Ratio | ★ $12.61 | $31.78 |
| Revenue Growth | ★ 6.54 | 3.62 |
| 52 Week Low | $264.10 | $79.55 |
| 52 Week High | $345.67 | $106.33 |
Technical Indicators
Market Signals| Indicator | CB | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 44.44 | 32.94 |
| Support Level | $321.21 | $85.60 |
| Resistance Level | $334.97 | $88.77 |
| Average True Range (ATR) | 4.91 | 1.59 |
| MACD | -1.09 | 0.18 |
| Stochastic Oscillator | 20.03 | 26.84 |
Price Performance
Historical ComparisonAbout CB Chubb Limited
ACE acquired Chubb in the first quarter of 2016 and assumed the Chubb name. The combination made the new Chubb one of the largest domestic property and casualty insurers, with operations in 54 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.